Chiasma is a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection.
Vaxcyte
5 followers
Tango Therapeutics
3 followers
Capricor Therapeutics
2 followers
Ascidian Therapeutics
2 followers
Gloucester Marine Genomics Institute
1 follower
Hound Labs
1 follower
Akero
1 follower
Elemental Enzymes
1 follower
Thermo Fisher Scientific
289 followers
Genentech
228 followers
Gilead Sciences
218 followers
Regeneron
187 followers